• No products in the cart.


This activity will address knowledge and practice gaps related to insulin therapy for patients with diabetes. Clinicians will be instructed on current unmet needs for basal insulin therapy, the pharmacokinetic and pharmacodynamic profiles of currently available basal insulin products, and the safety and efficacy of ultralong-acting basal insulin and assess their role in the treatment of patients with type 2 diabetes.

Learning Objectives:

  1. Discuss current unmet needs for basal insulin therapy.
  2. Outline the pharmacokinetic and pharmacodynamic profiles of currently available basal insulin products.
  3. Summarize the safety and efficacy of ultralong-acting basal insulin and assess their role in the treatment of patients with diabetes.
Target Audience:
This CME initiative is designed for Endocrinologists and Endocrine Fellows and other clinicians who care for patients with type 2 diabetes.

andrew ahmann

Andrew Ahmann, MD, MS
Professor of Medicine
Director, Harold Schnitzer Diabetes Health Center
Oregon Health & Science University
Portland, Oregon
Faculty Bio
Dr. Ahmann is a board certified endocrinologist with a special interest in the care of patients with diabetes. He is a Professor of Medicine at Oregon Health and Science University and has been the Director of the Harold Schnitzer Diabetes Health Center at OHSU since it opened in 2007 to provide state of the art care for children and adults with diabetes. Dr. Ahmann has served on regional and national committees developing and updating guidelines for the care of those with diabetes. Beyond patient care, he is active in medical education and research. His clinical research has addressed new therapies, new technologies and best practices for type 1 and type 2 diabetes. Dr. Ahmann is an active volunteer for causes that benefit those with diabetes, including the ADA, JDRF, and the Chris Dudley Basketball Camp for children with diabetes.
Launch Date/Expiration Date
This activity was launched on November 14, 2016  and will expire on November 1, 2017.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Horizon CME. Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Horizon CME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How To Claim Credit
By reviewing the course content and successfully completing the pre-test, post-test and evaluation, physicians are entitled to receive a maximum of 1.0 AMA PRA Category 1 Credits. Statement of credit will be available to print from your user history page.
• Read the learning objectives and faculty disclosures.
• Participate in the activity.
• Complete the pre-test and activity evaluation.
• Pass the post-test (3 of 4 correct).
Learner Assurance Statement
Horizon CME requires instructors, planners, managers and other individuals who are in a position to influence the content of this activity to disclose any real or apparent conflict of interest (COI) which may arise as a result of prospective faculty members’ relevant relationships with drug or device manufacturer(s). Horizon CME is committed to resolving all conflicts of interest and retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.
Name of Faculty/ Reported Financial Relationship
Dr. Ahmann has served on an Advisory Board for Lilly and Dexcom. Dr. Ahmann has performed contracted research for Sanofi, Novo Nordisk, Medtronic, Dexcom, and Lexicon
Content Reviewer:
Dawn Smiley-Byrd, MD, MSCR, Adjunct Associate Professor of Medicine,
Emory University School of Medicine, Staff Endocrinologist, Northside Hospital,
Atlanta, GA provided external review for this activity.
Content Reviewer:
Dr. Smiley-Byrd has served on a Speakers Bureau for Sanofi, Novo Nordisk, and Merck. She has also served on an Advisory Board for Sanofi and Novo Nordisk.
Other Contributors:
Others involved in the planning, development, and editing/review of the content disclosed no relevant financial relationships with any commercial interests.
Supporter Acknowledgement
Program supported by an educational grant from Sanofi US.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course Reviews


3 ratings
  • 5 stars2
  • 4 stars0
  • 3 stars1
  • 2 stars0
  • 1 stars0
  1. 5

    very good useful information clearly presented.

  2. RN review


    Good review with some new content

  • FREE
  • Course Certificate

Please contact the webmaster if you are experiencing any website performance issues. Be sure to include any relevant info such as your browser information, the pages affected, and/or pertinent screenshots of the issue.

Horizon CME

9123 SE St. Helens St. Suite 280
Clackamas, OR 97015

  Phone: (503) 659-5558
  Fax: (503) 716-3883

Copyright Horizon CME © 2017 - All Rights Reserved


Setup Menus in Admin Panel